-
-
-
-
-
-
-
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
-
-
-
-
-
-
-
Mangoceuticals clarifies GLP-1 weight-management program launch
-
-
-
-
-
-
-
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pou
-
-
-
-
-
-
-
Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based
-
-
-
-
-
-
-
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
-
-
-
-
-
-
-
Mangoceuticals (MGRX) Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
-
-
-
-
-
-
-
MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide
-
1,232,026 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


